Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Aug;47(8):769–770. doi: 10.1136/jcp.47.8.769

Pregnancy after treatment with hydroxyurea in a patient with primary thrombocythaemia and a history of recurrent abortion.

K I Cinkotai 1, P Wood 1, P Donnai 1, J Kendra 1
PMCID: PMC502158  PMID: 7962638

Abstract

A 28 year old patient with primary thrombocythaemia, who had had two stillbirths in the third trimester, is reported. She was successfully treated with hydroxyurea and delivered a healthy 6lb boy by elective caesarean section. The ease with which this treatment can be given, its high level of tolerance among patients, and its low cost are likely to increase its use as a safe and effective treatment in pregnant patients with primary thrombocythaemia.

Full text

PDF
769

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baer M. R., Ozer H., Foon K. A. Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br J Haematol. 1992 Jun;81(2):167–169. doi: 10.1111/j.1365-2141.1992.tb08202.x. [DOI] [PubMed] [Google Scholar]
  2. Beard J., Hillmen P., Anderson C. C., Lewis S. M., Pearson T. C. Primary thrombocythaemia in pregnancy. Br J Haematol. 1991 Mar;77(3):371–374. doi: 10.1111/j.1365-2141.1991.tb08586.x. [DOI] [PubMed] [Google Scholar]
  3. Delmer A., Rio B., Bauduer F., Ajchenbaum F., Marie J. P., Zittoun R. Pregnancy during myelosuppressive treatment for chronic myelogenous leukemia. Br J Haematol. 1992 Dec;82(4):783–784. doi: 10.1111/j.1365-2141.1992.tb06968.x. [DOI] [PubMed] [Google Scholar]
  4. Jackson N., Shukri A., Ali K. Hydroxyurea treatment for chronic myeloid leukaemia during pregnancy. Br J Haematol. 1993 Sep;85(1):203–204. doi: 10.1111/j.1365-2141.1993.tb08672.x. [DOI] [PubMed] [Google Scholar]
  5. Mercer B., Drouin J., Jolly E., d'Anjou G. Primary thrombocythemia in pregnancy: a report of two cases. Am J Obstet Gynecol. 1988 Jul;159(1):127–128. doi: 10.1016/0002-9378(88)90507-8. [DOI] [PubMed] [Google Scholar]
  6. Murphy S., Iland H., Rosenthal D., Laszlo J. Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group. Semin Hematol. 1986 Jul;23(3):177–182. [PubMed] [Google Scholar]
  7. Tertian G., Tchernia G., Papiernik E., Elefant E. Hydroxyurea and pregnancy. Am J Obstet Gynecol. 1992 Jun;166(6 Pt 1):1868–1868. doi: 10.1016/0002-9378(92)91590-7. [DOI] [PubMed] [Google Scholar]
  8. Vassiliadis S., Athanassakis I. Type II interferon may be a potential hazardous therapeutic agent during pregnancy. Br J Haematol. 1992 Dec;82(4):782–783. doi: 10.1111/j.1365-2141.1992.tb06967.x. [DOI] [PubMed] [Google Scholar]
  9. Williams D. W. Busulfan in early pregnancy. Obstet Gynecol. 1966 May;27(5):738–740. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES